Trials / Completed
CompletedNCT00954967
Trial for Tobacco Cessation With Intensive Advice in Diabetic Patients: the ITADI Project
Community Intervention Trial for Smoking Cessation With Intensive Advice in Diabetic Patients in Primary Health Care
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 722 (actual)
- Sponsor
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
This study addresses an important problem in public health, smoking in diabetics. The morbidity and mortality observed in diabetics is linked to macro and microvascular problems. The consumption of tobacco has a multiplying effect on these vascular problems in diabetics. This study aims to evaluate the effectiveness of an intensive intervention in tobacco addiction in diabetic patients in primary care.
Detailed description
Other objectives of the study are: 1. To study the effectiveness of an intensive smoking cessation intervention in the evolution of the phases of change, as based on the Prochaska and DiClemente model, in diabetic patients attended in primary care. 2. To evaluate the effectiveness of an intensive smoking cessation intervention in the evolution of tabacco consumption in diabetic patients attended in primary care. 3. To quantify the time spent in the intensive smoking cessation intervention compared with the usual care in primary care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Lifestyle Counseling | The intervention is based on lifestyle advice, motivational interviewing and the use of medications, using the Clinical Practice Guidelines of the Catalan Institute of Health. Health professionals in the intervention group receive a training on the abovementioned techniques. |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-01-01
- Completion
- 2011-09-01
- First posted
- 2009-08-07
- Last updated
- 2018-10-09
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00954967. Inclusion in this directory is not an endorsement.